178 related articles for article (PubMed ID: 30619317)
1. CD4
Preham O; Pinho FA; Pinto AI; Rani GF; Brown N; Hitchcock IS; Goto H; Kaye PM
Front Immunol; 2018; 9():2958. PubMed ID: 30619317
[TBL] [Abstract][Full Text] [Related]
2. Interferon-γ-Producing CD4
Romano A; Brown N; Ashwin H; Doehl JSP; Hamp J; Osman M; Dey N; Rani GF; Ferreira TR; Kaye PM
Front Immunol; 2021; 12():700501. PubMed ID: 34557190
[TBL] [Abstract][Full Text] [Related]
3. TNF signalling drives expansion of bone marrow CD4+ T cells responsible for HSC exhaustion in experimental visceral leishmaniasis.
Pinto AI; Brown N; Preham O; Doehl JSP; Ashwin H; Kaye PM
PLoS Pathog; 2017 Jul; 13(7):e1006465. PubMed ID: 28671989
[TBL] [Abstract][Full Text] [Related]
4. Leishmania donovani infection induces anemia in hamsters by differentially altering erythropoiesis in bone marrow and spleen.
Lafuse WP; Story R; Mahylis J; Gupta G; Varikuti S; Steinkamp H; Oghumu S; Satoskar AR
PLoS One; 2013; 8(3):e59509. PubMed ID: 23533629
[TBL] [Abstract][Full Text] [Related]
5. CD95 is required for the early control of parasite burden in the liver of Leishmania donovani-infected mice.
Alexander CE; Kaye PM; Engwerda CR
Eur J Immunol; 2001 Apr; 31(4):1199-210. PubMed ID: 11298345
[TBL] [Abstract][Full Text] [Related]
6. The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani.
Rostan O; Gangneux JP; Piquet-Pellorce C; Manuel C; McKenzie AN; Guiguen C; Samson M; Robert-Gangneux F
mBio; 2013 Sep; 4(5):e00383-13. PubMed ID: 24045639
[TBL] [Abstract][Full Text] [Related]
7. Splenic CD4+ T Cells in Progressive Visceral Leishmaniasis Show a Mixed Effector-Regulatory Phenotype and Impair Macrophage Effector Function through Inhibitory Receptor Expression.
Medina-Colorado AA; Osorio EY; Saldarriaga OA; Travi BL; Kong F; Spratt H; Soong L; Melby PC
PLoS One; 2017; 12(1):e0169496. PubMed ID: 28103263
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology.
Rosas LE; Satoskar AA; Roth KM; Keiser TL; Barbi J; Hunter C; de Sauvage FJ; Satoskar AR
Am J Pathol; 2006 Jan; 168(1):158-69. PubMed ID: 16400019
[TBL] [Abstract][Full Text] [Related]
9. Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells.
Stäger S; Maroof A; Zubairi S; Sanos SL; Kopf M; Kaye PM
Eur J Immunol; 2006 Jul; 36(7):1764-71. PubMed ID: 16791879
[TBL] [Abstract][Full Text] [Related]
10. HIF-1α hampers dendritic cell function and Th1 generation during chronic visceral leishmaniasis.
Hammami A; Abidin BM; Heinonen KM; Stäger S
Sci Rep; 2018 Feb; 8(1):3500. PubMed ID: 29472618
[TBL] [Abstract][Full Text] [Related]
11. Differential Induction of SOCS Isoforms by
Chandrakar P; Parmar N; Descoteaux A; Kar S
J Immunol; 2020 Feb; 204(3):596-610. PubMed ID: 31882519
[TBL] [Abstract][Full Text] [Related]
12. Leishmania donovani skews the CD56(+) Natural Killer T cell response during human visceral leishmaniasis.
Kumari S; Jamal F; Shivam P; Thakur A; Kumar M; Bimal S; Das VN; Pandey K; Narayan S; Gupta AK; Das P; Singh SK
Cytokine; 2015 May; 73(1):53-60. PubMed ID: 25697139
[TBL] [Abstract][Full Text] [Related]
13. Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection.
Engwerda CR; Ato M; Stäger S; Alexander CE; Stanley AC; Kaye PM
Am J Pathol; 2004 Dec; 165(6):2123-33. PubMed ID: 15579454
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic glucocorticoid-induced TNF receptor-mediated amplification of CD4+ T cell responses enhances antiparasitic immunity.
Haque A; Stanley AC; Amante FH; Rivera Fde L; Zhou Y; Kuns RD; Yardley V; Sakaguchi S; Hill GR; Engwerda CR
J Immunol; 2010 Mar; 184(5):2583-92. PubMed ID: 20139272
[TBL] [Abstract][Full Text] [Related]
15. Cutting edge: STAT1 and T-bet play distinct roles in determining outcome of visceral leishmaniasis caused by Leishmania donovani.
Rosas LE; Snider HM; Barbi J; Satoskar AA; Lugo-Villarino G; Keiser T; Papenfuss T; Durbin JE; Radzioch D; Glimcher LH; Satoskar AR
J Immunol; 2006 Jul; 177(1):22-5. PubMed ID: 16785492
[TBL] [Abstract][Full Text] [Related]
16. Intranasal vaccine from whole Leishmania donovani antigens provides protection and induces specific immune response against visceral leishmaniasis.
Helou DG; Mauras A; Fasquelle F; Lanza JS; Loiseau PM; Betbeder D; Cojean S
PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009627. PubMed ID: 34403413
[TBL] [Abstract][Full Text] [Related]
17. Leishmania donovani phosphoproteins pp41 and pp29 re-establishes host protective immune response in visceral leishmaniasis.
Das P; Amit A; Singh SK; Chaudhary R; Dikhit MR; Yadav A; Pandey K; Das VN; Sundram S; Das P; Bimal S
Parasitol Int; 2015 Feb; 64(1):18-25. PubMed ID: 25224164
[TBL] [Abstract][Full Text] [Related]
18. IL-27 signalling regulates glycolysis in Th1 cells to limit immunopathology during infection.
Montes de Oca M; de Labastida Rivera F; Winterford C; Frame TCM; Ng SS; Amante FH; Edwards CL; Bukali L; Wang Y; Uzonna JE; Kuns RD; Zhang P; Kabat A; Klein Geltink RI; Pearce EJ; Hill GR; Engwerda CR
PLoS Pathog; 2020 Oct; 16(10):e1008994. PubMed ID: 33049000
[TBL] [Abstract][Full Text] [Related]
19. IFN-γ
Yadav S; Prakash J; Singh OP; Gedda MR; Chauhan SB; Sundar S; Dubey VK
Cell Immunol; 2021 Mar; 361():104272. PubMed ID: 33445051
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 2 is an Upstream Regulator of CD4+ T Cells From Visceral Leishmaniasis Patients With Therapeutic Potential.
Chauhan SB; Faleiro R; Kumar R; Ng S; Singh B; Singh OP; Singh SS; Amante F; Rivera FL; Rai M; Chakravarty J; Sacks D; Nylen S; Sundar S; Engwerda C
J Infect Dis; 2019 Jun; 220(1):163-173. PubMed ID: 30796820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
